单胎与双胎妊娠中孕妇血游离DNA检测筛查唐氏综合征的失败影响因素
该前瞻性研究纳入23 495例单胎和928例双胎妊娠,在孕10+0至14+1周行靶向cfDNA检测筛查21、18、13三体。首次采样后单胎无结果率3.4%(798/23 495),双绒毛膜双胎11.3%(91/806),单绒毛膜双胎4.9%(6/122)。多因素分析显示母亲年龄、体重、种族、产次、孕龄、绒毛膜性、受孕方式及血清free β-hCG和PAPP-A MoM是检测失败的独立预测因素。
要点
- 单胎首次cfDNA检测无结果率为3.4%(798/23 495),双绒毛膜双胎为11.3%(91/806),单绒毛膜双胎为4.9%(6/122)。
- 母亲年龄较大、体重较高、孕龄较小、PAPP-A MoM和free β-hCG MoM较低与检测失败风险升高相关。
- 黑人(OR 1.72)和南亚裔(OR 1.99)较白人、双绒毛膜双胎较单胎(OR 1.75)、体外受精较自然受孕(OR 3.82)检测失败风险更高,经产妇较初产妇更低(OR 0.63)。
核心结论
- 母亲年龄、体重、种族、产次、孕龄、双绒毛膜性、受孕方式及血清free β-hCG和PAPP-A水平是cfDNA检测失败的独立预测因素。
- 双绒毛膜双胎较单胎检测失败风险更高,主要因双胎中体外受精比例更高且初产妇更多。
研究设计与样本
- 前瞻性研究,纳入23 495例单胎和928例双胎妊娠,于孕10+0至14+1周行靶向cfDNA检测筛查胎儿21、18、13三体,采用多因素logistic回归分析首次采样后检测失败的显著预测因素。
主要发现
- 首次采样后无cfDNA检测结果:单胎3.4%(798/23 495),双绒毛膜双胎11.3%(91/806),单绒毛膜双胎4.9%(6/122)。
- 检测失败风险随母亲年龄增加(OR 1.02;95%CI 1.01-1.04)和体重增加(OR 1.05;95%CI 1.04-1.05)而升高。
- 检测失败风险随孕龄增加(OR 0.85;95%CI 0.79-0.91)、PAPP-A MoM升高(OR 0.56;95%CI 0.49-0.65)和free β-hCG MoM升高(OR 0.67;95%CI 0.60-0.74)而降低。
- 黑人(OR 1.72;95%CI 1.33-2.20)和南亚裔(OR 1.99;95%CI 1.56-2.52)较白人种族检测失败风险更高。
- 双绒毛膜双胎较单胎(OR 1.75;95%CI 1.34-2.26)及体外受精较自然受孕(OR 3.82;95%CI 3.19-4.55)检测失败风险更高,经产妇较初产妇更低(OR 0.63;95%CI 0.55-0.74)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine factors affecting the rate of failure to obtain a result from cell-free DNA (cfDNA) testing of maternal blood for fetal trisomies 21, 18 and 13 in singleton and twin pregnancies in the first trimester. METHODS: This was a prospective study of 23 495 singleton and 928 twin pregnancies undergoing screening for fetal trisomy by targeted cfDNA testing at 10 + 0 to 14 + 1 weeks' gestation. Multivariate logistic regression analysis was used to determine significant predictors of failure to obtain a result after first sampling. RESULTS: There was no result from cfDNA testing after first sampling in 3.4% (798/23 495) of singletons, 11.3% (91/806) of dichorionic twins and 4.9% (6/122) of monochorionic twins. Multivariate logistic regression analysis demonstrated that the risk of test failure, first, increased with increasing maternal age (odds ratio (OR), 1.02; 95% CI, 1.01-1.04) and weight (OR, 1.05; 95% CI, 1.04-1.05), decreasing gestational age (OR, 0.85; 95% CI, 0.79-0.91), serum pregnancy-associated plasma protein-A (PAPP-A) multiples of the median (MoM) (OR, 0.56; 95% CI, 0.49-0.65) and free β-human chorionic gonadotropin (β-hCG) MoM (OR, 0.67; 95% CI, 0.60-0.74), second, was higher in women of black (OR, 1.72; 95% CI, 1.33-2.20) and South Asian (OR, 1.99; 95% CI, 1.56-2.52) than those of white racial origin, in dichorionic twin than in singleton pregnancy (OR, 1.75; 95% CI, 1.34-2.26) and in pregnancies conceived by in-vitro fertilization than in those conceived naturally (OR, 3.82; 95% CI, 3.19-4.55) and, third, was lower in parous than in nulliparous women (OR, 0.63; 95% CI, 0.55-0.74). CONCLUSIONS: Maternal age, weight, racial origin and parity, gestational age, dichorionicity, method of conception and serum levels of free β-hCG and PAPP-A are independent predictors of cfDNA test failure. The risk of test failure is higher in dichorionic twin than in singleton pregnancies, mainly because a higher proportion of twins are conceived by in-vitro fertilization and more of the women are nulliparous. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.
引用
- Galeva S, Gil MM, Konstantinidou L, et al. First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure. Ultrasound Obstet Gynecol. 2019. PMID: 30977206. doi:10.1002/uog.20290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。